Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
about
The role of natriuretic peptides for the diagnosis of left ventricular dysfunctionAdiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients.Emergency department and office-based evaluation of patients with chest pain.High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failureRecognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjectsLong-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat modelRenal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failureGenetic variation in the natriuretic peptide system and heart failure.Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials.Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.The utility of BNP in clinical practice.Brain natriuretic peptide in the contemporary management of congestive heart failure.Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation.Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failureB-type natriuretic peptide: a critical review.Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide.Natriuretic peptides in chronic kidney disease.Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of the literature and clinical recommendationsEffects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.Natriuretic peptides in heart failure: where we are, where we are going.Tailored therapy for heart failure: neurohormones.Clinical utility of natriuretic peptides in dialysis patients.The diagnostic utility of cardiac biomarkers in dialysis patients.Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure.The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.Predictive factors for high brain (B-type) natriuretic peptide at discharge in properly treated heart failure patients.Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation.Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in end-stage renal disease patients with preserved left ventricular ejection fraction.The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy.Prognostic implications of left ventricular dilation in patients with nonischemic heart failure: interactions with restrictive filling pattern and mitral regurgitation.Factors determining extreme brain natriuretic peptide elevation.What is causing extremely elevated amino terminal brain natriuretic peptide in cancer patients?
P2860
Q26825665-DED1CFC4-190F-4098-BA02-653FAAB30F71Q30461204-ED5D213A-C6B0-4F69-9035-B20A815957E5Q30485218-1EE953FA-14AE-42C7-82F9-36905C599A8CQ33744203-43384471-AE97-4564-9212-7149F5339DCAQ33751298-7D783950-C878-48A8-B0B2-6B28BB5B0CFDQ33902623-F05D6FBB-132B-4A93-83BF-81FD87392355Q34203867-3A63F552-ABA6-4C59-A49E-97F9B7CE0D51Q34561996-E5E53EA6-CE56-4174-BF99-416ADEED79A5Q34891600-27175DB5-2E15-4EFD-89FE-9A99B7E9BBC8Q35017352-AFA1E562-6F6E-4D24-B620-E794E1179357Q35046791-7EE2BAFE-2B80-42EE-88C2-4650DF162CBDQ35109460-31730334-716E-4BA3-9288-40974C6B290AQ35131225-75B34BD8-9F81-4F5F-8397-9BD607DBAD2BQ35179984-D4EC755F-4FF6-4AFB-9BFE-162797316F7DQ35772139-6086754F-621C-4E3D-8EFA-7DAD2268EDE3Q35856451-9171BDA9-5766-497E-8B07-4601BE14364BQ36050481-D0656596-B58B-4C57-B02B-16D129D1C7B6Q36146288-880C88C4-17B2-4566-8862-C81994AC8114Q36281136-27BAF7C0-6E60-498B-90BE-3DC839004980Q36593515-0E63AF06-7427-41A0-86FF-7C500196719EQ36724549-AB14E468-7D12-4285-B491-0C948CD63FACQ36732168-9D25E0BF-F818-425D-85B2-1B7E49DE808BQ36931415-E550E531-E45E-49E0-8141-56C8BA0EAA83Q36947290-015D0775-1109-44F3-B278-3F8A4DAAECD6Q36951519-936C64A3-4B7B-4258-B0BA-C0375D334110Q36969041-9BF8E1B5-A8A4-4ADC-A7EC-AA1F8D1C4496Q37435182-1364E3F0-3A02-40CB-A331-8AD817C098DBQ37790310-3B9ED956-C258-4C89-AC26-470D4FFB7BCCQ37910927-85B4E9D0-F834-4529-8791-E894D0335448Q38011232-32853AD7-8052-409E-9610-607D8C306A32Q38022786-1BB82BDE-169B-4ECE-B5A6-EDE5ABAB783CQ43411896-A3FD9864-A1B5-43EF-8108-182A9D83F462Q44338728-B700DF4B-2579-4134-802A-A2995787797EQ44635594-8A9CF9E7-0486-44AD-9E33-ABC8005BA7A1Q45250859-98F4368D-158B-4AB4-868A-20E3066F6FE7Q46601541-7CA64E48-99A8-4CE9-B263-AD2EC32A5D92Q46640349-FEB21E85-812B-42A1-9F41-D76ECE4F5610Q47892982-7FD2AAC3-5795-4AFE-ABE1-0C13F94C4255Q48150107-310F769C-63AC-4886-9D67-C9AA111B5BE4Q48230566-605B3242-99CD-4D1B-A7DD-01FF617E92D8
P2860
Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Plasma B-type natriuretic pept ...... ventricular systolic function.
@en
Plasma B-type natriuretic pept ...... ventricular systolic function.
@nl
type
label
Plasma B-type natriuretic pept ...... ventricular systolic function.
@en
Plasma B-type natriuretic pept ...... ventricular systolic function.
@nl
prefLabel
Plasma B-type natriuretic pept ...... ventricular systolic function.
@en
Plasma B-type natriuretic pept ...... ventricular systolic function.
@nl
P2093
P50
P921
P1476
Plasma B-type natriuretic pept ...... ventricular systolic function
@en
P2093
A Mark Richards
Allan L Klein
Annette Fogarty
Annitta Morehead
David L Prior
James B Young
James D Thomas
Jeremy J Pereira
Maureen Martin
P304
P356
10.1016/J.JACC.2003.08.046
P407
P577
2004-02-01T00:00:00Z